The voluntary withdrawal covers all GlucoPro syringes with expiration dates before November 2011, but does not include syringes designed for use with Nipro’s Amigo insulin pump.
The firm, which is owned by Japan’s Nipro Corporation, said it has informed the US Food and Drug Administration of the recall and added that it has received no reports of injuries associated with the GlucoPro product.
Nipro is the second syringe maker to be hit by such problems in the last six months behind Qualitest Pharmaceuticals, which pulled 250m of its Accusure prefilled insulin needles in October.